GlaxoSmithKline PLC Director/PDMR Shareholding (6530N)
August 10 2017 - 5:50AM
UK Regulatory
TIDMGSK
RNS Number : 6530N
GlaxoSmithKline PLC
10 August 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ==========================================================================================
a) Name Mrs V A Whyte
==== ====================================== ==================================================
b) Position/status SVP & Company Secretary
==== ====================================== ==================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ==================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ==================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ==================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ==================================================
b) Nature of the The receipt of 4,360 Ordinary Shares from
transaction spouse for nil consideration.
==== ====================================== ==================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================= ======================
GBP0.00 4,360
=================================================================== ======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================ =============================
e) Date of the transaction 2017-08-09
==== ====================================== ==================================================
f) Place of the transaction n/a
==== ====================================== ==================================================
Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr I W Whyte
==== ====================================== ====================================================
b) Position/status PCA of Mrs V A Whyte (SVP & Company Secretary)
==== ====================================== ====================================================
c) Initial notification/ Initial Notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Transfer of 4,360 Ordinary Shares to spouse
transaction for nil consideration.
==== ====================================== ====================================================
c) Price(s) and volume(s) Price(s) Volume(s)
==== ====================================== ======================== =======================
GBP0.00 4,360
==================================================================== =======================
d) Aggregated information n/a (single transaction)
====
Aggregated volume
Price
================================================================= ==============================
e) Date of the transaction 2017-08-09
==== ====================================== ====================================================
f) Place of the transaction n/a
==== ====================================== ====================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHKBLBFDVFZBBV
(END) Dow Jones Newswires
August 10, 2017 05:50 ET (09:50 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024